Literature DB >> 22616398

Which orphans will find a home? The rule of rescue in resource allocation for rare diseases.

Emily A Largent1, Steven D Pearson.   

Abstract

Mesh:

Year:  2012        PMID: 22616398     DOI: 10.1002/hast.12

Source DB:  PubMed          Journal:  Hastings Cent Rep        ISSN: 0093-0334            Impact factor:   2.683


× No keyword cloud information.
  14 in total

1.  [Rare diseases: laying out some challenges].

Authors: 
Journal:  Cambios Rev Med       Date:  2017-01

Review 2.  Two decades of off-label prescribing in children: a literature review.

Authors:  Shamala Balan; Mohamed Azmi Ahmad Hassali; Vivienne S L Mak
Journal:  World J Pediatr       Date:  2018-09-14       Impact factor: 2.764

3.  Management of hereditary angioedema in 2012: scientific and pharmacoeconomic perspectives.

Authors:  Stephen A Tilles; Larry Borish; Joshua P Cohen
Journal:  Ann Allergy Asthma Immunol       Date:  2012-12-17       Impact factor: 6.347

4.  For the Sake of Justice: Should We Prioritize Rare Diseases?

Authors:  Niklas Juth
Journal:  Health Care Anal       Date:  2017-03

5.  From "Ought" to "Is": Surfacing Values in Patient and Family Advocacy in Rare Diseases.

Authors:  Meghan C Halley
Journal:  Am J Bioeth       Date:  2021-12       Impact factor: 11.229

Review 6.  A systematic review of moral reasons on orphan drug reimbursement.

Authors:  Bettina M Zimmermann; Johanna Eichinger; Matthias R Baumgartner
Journal:  Orphanet J Rare Dis       Date:  2021-06-30       Impact factor: 4.123

7.  Value-based reimbursement decisions for orphan drugs: a scoping review and decision framework.

Authors:  Mike Paulden; Tania Stafinski; Devidas Menon; Christopher McCabe
Journal:  Pharmacoeconomics       Date:  2015-03       Impact factor: 4.981

8.  Identifying priority medicines policy issues for New Zealand: a general inductive study.

Authors:  Zaheer-Ud-Din Babar; Susan Francis
Journal:  BMJ Open       Date:  2014-05-28       Impact factor: 2.692

9.  Are payers treating orphan drugs differently?

Authors:  Joshua P Cohen; Abigail Felix
Journal:  J Mark Access Health Policy       Date:  2014-01-15

Review 10.  Systematic review on the evaluation criteria of orphan medicines in Central and Eastern European countries.

Authors:  Tamás Zelei; Mária J Molnár; Márta Szegedi; Zoltán Kaló
Journal:  Orphanet J Rare Dis       Date:  2016-06-04       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.